Biointaxis
Badalona, ES · 1 known investors
Biointaxis is an academic biotech spin-off developing a gene therapy to restore the function of a defective protein in patients with Friedreich's ataxia, a rare inherited neurodegenerative disease. The company handles early-stage R&D, pre-clinical, and early clinical (Phase I/II) development, aiming to license production and distribution rights to pharmaceutical partners.
BiotechHealthtechMedical Devices
Founders & leadership
AM
Antoni Matilla DueñasCEO & Co-Founder
IS
Ivelisse SánchezCSO & Co-Founder
JM
Jaime MelendoBoard Member & Co-Founder
DP
Daniel PérezChief Financial Officer